| Pitfalls in the measurement and interpretation of thyroid function tests O Koulouri, C Moran, D Halsall, K Chatterjee, M Gurnell Best practice & research Clinical endocrinology & metabolism 27 (6), 745-762, 2013 | 344 | 2013 |
| An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor α C Moran, N Schoenmakers, M Agostini, E Schoenmakers, A Offiah, ... The Journal of Clinical Endocrinology & Metabolism 98 (11), 4254-4261, 2013 | 143 | 2013 |
| Diagnosis and management of central diabetes insipidus in adults A Garrahy, C Moran, CJ Thompson Clinical endocrinology 90 (1), 23-30, 2019 | 136 | 2019 |
| Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR) α1 and TRα2: clinical, biochemical, and genetic analyses of three related patients C Moran, M Agostini, WE Visser, E Schoenmakers, N Schoenmakers, ... The lancet Diabetes & endocrinology 2 (8), 619-626, 2014 | 120 | 2014 |
| Resistance to thyroid hormone due to defective thyroid receptor alpha C Moran, K Chatterjee Best practice & research Clinical endocrinology & metabolism 29 (4), 647-657, 2015 | 117 | 2015 |
| Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial S Groeneweg, RP Peeters, C Moran, A Stoupa, F Auriol, D Tonduti, ... The Lancet Diabetes & Endocrinology 7 (9), 695-706, 2019 | 110 | 2019 |
| Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism K Boelaert, WE Visser, PN Taylor, C Moran, J Léger, L Persani European journal of endocrinology 183 (1), G33-G39, 2020 | 109 | 2020 |
| Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis E Schoenmakers, B Carlson, M Agostini, C Moran, O Rajanayagam, ... The Journal of clinical investigation 126 (3), 992-996, 2016 | 90 | 2016 |
| 2019 European Thyroid Association guidelines on the management of thyroid dysfunction following immune reconstitution therapy I Muller, C Moran, B Lecumberri, B Decallonne, N Robertson, J Jones, ... European thyroid journal 8 (4), 173-185, 2019 | 76 | 2019 |
| Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features N Pariani, M Willis, I Muller, S Healy, T Nasser, A McGowan, G Lyons, ... The Journal of Clinical Endocrinology & Metabolism 103 (8), 3010-3018, 2018 | 71 | 2018 |
| Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge D Cartwright, P O'Shea, O Rajanayagam, M Agostini, P Barker, C Moran, ... Clinical chemistry 55 (5), 1044-1046, 2009 | 69 | 2009 |
| Resistance to thyroid hormone mediated by defective thyroid hormone receptor alpha N Schoenmakers, C Moran, RP Peeters, T Visser, M Gurnell, K Chatterjee Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (7), 4004-4008, 2013 | 67 | 2013 |
| Central pontine myelinolysis complicating treatment of the hyperglycaemic hyperosmolar state G O'Malley, C Moran, MS Draman, T King, D Smith, CJ Thompson, ... Annals of clinical biochemistry 45 (4), 440-443, 2008 | 67 | 2008 |
| Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study S Groeneweg, FS van Geest, A Abacı, A Alcantud, GP Ambegaonkar, ... The Lancet Diabetes & Endocrinology 8 (7), 594-605, 2020 | 66 | 2020 |
| Resistance to thyroid hormone due to heterozygous mutations in thyroid hormone receptor alpha ALM van Gucht, C Moran, ME Meima, WE Visser, K Chatterjee, TJ Visser, ... Current topics in developmental biology 125, 337-355, 2017 | 66 | 2017 |
| Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study JWL Brown, NG Cunniffe, F Prados, B Kanber, JL Jones, E Needham, ... The Lancet Neurology 20 (9), 709-720, 2021 | 60 | 2021 |
| Contrasting phenotypes in resistance to thyroid hormone alpha correlate with divergent properties of thyroid hormone receptor α1 mutant proteins C Moran, M Agostini, A McGowan, E Schoenmakers, L Fairall, G Lyons, ... Thyroid 27 (7), 973-982, 2017 | 55 | 2017 |
| Investigation of soluble and transmembrane CTLA-4 isoforms in serum and microvesicles L Esposito, K Hunter, J Clark, DB Rainbow, H Stevens, J Denesha, ... The Journal of Immunology 193 (2), 889-900, 2014 | 47 | 2014 |
| Resistance to thyroid hormone α–emerging definition of a disorder of thyroid hormone action C Moran, K Chatterjee The Journal of Clinical Endocrinology & Metabolism 101 (7), 2636-2639, 2016 | 44 | 2016 |
| Anterior hypopituitarism is rare and autoimmune disease is common in adults with idiopathic central diabetes insipidus MJ Hannon, C Orr, C Moran, LA Behan, A Agha, SG Ball, CJ Thompson Clinical Endocrinology 76 (5), 725-728, 2012 | 37 | 2012 |
